More about

Methotrexate

News
July 03, 2023
5 min watch
Save

VIDEO: Biggest challenges in RA treatment

VIDEO: Biggest challenges in RA treatment

In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discussed some of the biggest challenges in treating rheumatoid arthritis, including issues with infections and other comorbidities.

News
June 27, 2023
2 min read
Save

Switching to monotherapy for rheumatoid arthritis more effective for patients in LDA

Switching to monotherapy for rheumatoid arthritis more effective for patients in LDA

Patients with rheumatoid arthritis who have lower disease activity are more likely to remain in remission after switching from combination therapy to monotherapy, according to data published in The Journal of Rheumatology.

News
June 19, 2023
2 min read
Save

Biologic DMARDs control ICI-associated inflammatory arthritis quicker than methotrexate

Biologic DMARDs control ICI-associated inflammatory arthritis quicker than methotrexate

Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic DMARD demonstrate quicker arthritis control, but also experience faster cancer progression, vs. methotrexate, according to data.

News
June 15, 2023
2 min read
Save

ASCO chief medical officer appeals to Congress for action on cancer-drug shortages

ASCO chief medical officer appeals to Congress for action on cancer-drug shortages

ASCO Chief Medical Officer Julie R. Gralow, MD, FACP, FASCO, urged members of Congress to take action on cancer drug shortages, which she described as the worst she has witnessed during her 30-year career in oncology.

News
May 11, 2023
1 min read
Save

Central nervous system vasculitis treatment strategies still lack strong data

Central nervous system vasculitis treatment strategies still lack strong data

Current treatment strategies for patients with central nervous system vasculitis are not based on high-grade scientific evidence but rather expert opinion, according to a speaker at the Biologic Therapies Summit.

News
May 05, 2023
3 min read
Save

‘Treatment is not one size fits all’: Sarcoidosis management must be individualized

‘Treatment is not one size fits all’: Sarcoidosis management must be individualized

DESTIN, Fla. — Complicated disease pathogenesis and a lack of FDA-approved therapies makes sarcoidosis a significant clinical challenge, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

News
April 20, 2023
2 min read
Save

Adalimumab plus methotrexate lowers treatment failure 2-fold in pediatric Crohn’s

Adalimumab plus methotrexate lowers treatment failure 2-fold in pediatric Crohn’s

Combination therapy with adalimumab plus low-dose methotrexate induced a two-fold reduction of treatment failure among pediatric patients with Crohn’s disease, according to research published in Gastroenterology.

News
April 20, 2023
1 min read
Save

Methotrexate may increase skin cancer risk in patients with psoriasis

Methotrexate may increase skin cancer risk in patients with psoriasis

Psoriasis patients taking methotrexate are nearly three times as likely to develop nonmelanoma skin cancer compared with those not taking the drug, according to a study.

News
April 13, 2023
2 min read
Save

Trial results show gout therapy of pegloticase, methotrexate maintained eGFR vs. placebo

Trial results show gout therapy of pegloticase, methotrexate maintained eGFR vs. placebo

AUSTIN, Texas —Results from a poster presentation here showed that patients with uncontrolled gout treated with the combined therapy of pegloticase and methotrexate saw a reduction in gout symptoms as well as a stable eGFR.

News
March 27, 2023
2 min read
Save

Methotrexate, low-dose prednisone aids hair regrowth in patients with alopecia subtypes

Methotrexate, low-dose prednisone aids hair regrowth in patients with alopecia subtypes

Methotrexate and low-dose prednisone combination outperformed methotrexate alone in patients with chronic and recalcitrant alopecia totalis and alopecia universalis, according to a study.

View more